Loading...
Market
What percentage of Medicare beneficiaries will benefit from the $2,000 drug cost cap in 2025?
2
Resolution / Starting Odds
Less than 50% • 25%
50% to 70% • 25%
70% to 90% • 25%
More than 90% • 25%
Data from Medicare reports or healthcare studies
Story
Medicare Drug Costs Capped at $2,000 Annually Starting January 1, 2025, Benefiting 19 Million with $400 Savings
Jan 2, 2025, 06:03 PM
A key provision of the Inflation Reduction Act, which limits annual out-of-pocket spending on prescription drugs to $2,000 for Medicare beneficiaries, went into effect on January 1, 2025. This measure is expected to benefit millions of seniors, with an estimated 19 million people saving an average of $400 each. The cap applies to drugs purchased at the pharmacy or through mail order, marking a significant change from previous years where no such cap existed for Medicare Part D enrollees. The Inflation Reduction Act, passed by Democrats, also includes other measures aimed at reducing drug costs, such as a $35 monthly cap on insulin prescriptions and allowing Medicare to negotiate drug prices.
View original story
Similar markets
71% to 90% • 25%
Less than 50% • 25%
50% to 70% • 25%
More than 90% • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
$1,000 to $2,000 • 25%
Less than $500 • 25%
$500 to $1,000 • 25%
More than $2,000 • 25%
Less than 10% • 25%
20% to 30% • 25%
More than 30% • 25%
10% to 20% • 25%
Less than $5 billion • 25%
$5 billion to $10 billion • 25%
$10 billion to $15 billion • 25%
More than $15 billion • 25%
No • 50%
Yes • 50%
More than 75% • 25%
Less than 25% • 25%
25% to 50% • 25%
50% to 75% • 25%
More than 30% • 25%
21% to 30% • 25%
10% to 20% • 25%
Less than 10% • 25%
High-income beneficiaries • 25%
Low-income beneficiaries • 25%
Middle-income beneficiaries • 25%
Pharmaceutical companies • 25%